Menu

• Ask a Health Expert about NEUROGENIC BLADDER
• Post Your Side Effect related to NEUROGENIC BLADDER
• NEUROGENIC BLADDER and FDA Warnings
• NEUROGENIC BLADDER in Patients Wiki
• Report NEUROGENIC BLADDER in Drug Side Effect Survey

NEUROGENIC BLADDER side effect

What is NEUROGENIC BLADDER ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Vincristine Side Effects Report #5652551-X
Health Professional from TURKEY reported VINCRISTINE SULPHATE problem on Mar 03, 2008. Male patient, child 10 years of age, was diagnosed with rhabdomyosarcoma and was treated with VINCRISTINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, neuropathy peripheral, . VINCRISTINE SULPHATE dosage: CUMULATIVE DOSE OF 16.5MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.

Vincristine Side Effects Report #5654584-6
VINCRISTINE SULPHATE problem was reported by a Health Professional from TURKEY on Mar 04, 2008. Male patient, child 10 years of age, was diagnosed with rhabdomyosarcoma and was treated with VINCRISTINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, neuropathy peripheral, . VINCRISTINE SULPHATE dosage: CUMULATIVE DOSE OF 16.5MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.

Velcade Side Effects Report #5617247-9
Physician from JAPAN reported VELCADE problem on Jan 24, 2008. Male patient, 60 years of age, weighting 169.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, . VELCADE dosage: 2.30 MG, INTRAVENOUS; 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with TIZANIDINE, MUCOSTA, OMEPRAZOLE, AMLODIPINE BESYLATE, OLMETEC, TAMSULOSIN, UBRETID. Patient recovered.

Detrusitol Side Effects Report #5584729-8
DETRUSITOL problem was reported by a Health Professional from UNITED KINGDOM on Dec 31, 2007. Male patient, 62 years of age, weighting 172.0 lb, was diagnosed with hypertonic bladder, benign prostatic hyperplasia and was treated with DETRUSITOL. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, urinary retention, . DETRUSITOL dosage: unknown. During the same period patient was treated with FLOMAX. Patient recovered.


Velcade Side Effects Report #5477585-X
Physician from JAPAN reported VELCADE problem on Sept 20, 2007. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, . VELCADE dosage: unknown. Patient recovered.

Velcade Side Effects Report #5413405-7
VELCADE problem was reported by a Physician from JAPAN on Mar 08, 2007. Female patient, 69 years of age, weighting 110.2 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, . VELCADE dosage: 1.00 MG/M2, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with DECADRON. Patient recovered.

Cymbalta Side Effects Report #5779486-6
Physician from SPAIN reported CYMBALTA problem on June 10, 2008. Male patient, 72 years of age, was diagnosed with depression, hyperuricaemia, hypertension, insomnia and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, . CYMBALTA dosage: unknown. During the same period patient was treated with ALLOPURINOL, LIMOVAN, ALOPURINOL, ANTIHYPERTENSIVES, ZOLPIDEM. Patient recovered.

Depocyt Side Effects Report #5742443-X
DEPOCYT problem was reported by a Physician from GERMANY on Apr 25, 2008. Female patient, 72 years of age, weighting 149.9 lb, was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, paresis anal sphincter, . DEPOCYT dosage: 50 MG; X4; INTH. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, METHOTREXATE, IFOSFAMIDE, METOPROLOL TARTRATE, PANTOPRAZOLE, CHLORIDE, ZOPICLONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5724685-2
Physician from JAPAN reported VELCADE problem on Apr 17, 2008. Male patient, 60 years of age, weighting 169.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, . VELCADE dosage: 2.30 MG, INTRAVENOUS; 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with TIZANIDINE, MUCOSTA, OMEPRAZOLE, AMLODIPINE BESYLATE, OLMESARTAN MEDOXOMIL, TAMSULOSIN, UBRETID. Patient recovered.


Clonazepam Side Effects Report #5328427-4
CLONAZEPAM problem was reported by a Consumer or non-health professional from UNITED STATES on May 16, 2007. Male patient, 50 years of age, weighting 190.0 lb, was diagnosed with schizophrenia and was treated with CLONAZEPAM. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, . CLONAZEPAM dosage: 0.5 MG ONE PER DAY BUCCAL. Patient recovered.

Cymbalta Side Effects Report #5340968-2
Consumer or non-health professional from UNITED STATES reported CYMBALTA problem on Jan 23, 2007. Male patient, 62 years of age, was diagnosed with bipolar disorder and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, . CYMBALTA dosage: 90 MG, DAILY (1/D); ORAL. During the same period patient was treated with LAMICTAL. Patient recovered.

Revatio Side Effects Report #5264033-8
REVATIO problem was reported by a Physician from ISRAEL on Mar 05, 2007. Female patient, 49 years of age, was diagnosed with pulmonary hypertension and was treated with REVATIO. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, urinary tract infection, . REVATIO dosage: DAILY DOSE:225MG. Patient recovered.

Revatio Side Effects Report #5282198-9
Physician from ISRAEL reported REVATIO problem on Mar 22, 2007. Female patient, 49 years of age, was diagnosed with pulmonary hypertension and was treated with REVATIO. After drug was administered, patient experienced the following problems/side effects: neurogenic bladder, urinary tract infection, . REVATIO dosage: DAILY DOSE:225MG. Patient recovered.

Aricept Side Effects Report #5618694-1
ARICEPT problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Male patient, 85 years of age, was treated with ARICEPT. After drug was administered, patient experienced the following problems/side effects: bladder pain, neurogenic bladder, no therapeutic response, . ARICEPT dosage: unknown. During the same period patient was treated with NIASPAN, COUMADIN, TRILEPTAL, ASPIRIN, LISINOPRIL. Patient recovered.


Vincristine Side Effects Report #5625891-8
Physician from TURKEY reported VINCRISTINE problem on Jan 29, 2008. Male patient, child 10 years of age, was diagnosed with rhabdomyosarcoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: constipation, neurogenic bladder, neuropathy peripheral, peroneal nerve palsy, . VINCRISTINE dosage: unknown. During the same period patient was treated with ACTINOMYSIN, CYCLOPHOSPHAMIDE. Patient recovered.

Mylotarg Side Effects Report #5633436-1
MYLOTARG problem was reported by a Physician from JAPAN on Feb 15, 2008. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia, neutropenia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, neurogenic bladder, pneumonia, venoocclusive liver disease, . MYLOTARG dosage: unknown. During the same period patient was treated with PREDONINE, VANCOMYCIN, MEROPENEM, AMBISOME. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5585233-3
Physician from JAPAN reported MYLOTARG problem on Jan 07, 2008. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia, neutropenia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, neurogenic bladder, pneumonia, venoocclusive liver disease, . MYLOTARG dosage: unknown. During the same period patient was treated with PREDONINE, VANCOMYCIN, MEROPENEM, AMBISOME. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5599253-6
AVONEX problem was reported by a Health Professional from UNITED STATES on Jan 07, 2008. Female patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, neurogenic bladder, . AVONEX dosage: unknown. During the same period patient was treated with TOPAMAX, PREDNISONE, CELEXA, LYRICA, MIRALAX, OXYCONTIN, SEROQUEL, RELPAX. Patient was hospitalized. Patient recovered.

Remicade Side Effects Report #5521038-7
Physician from UNITED STATES reported REMICADE problem on Nov 09, 2007. Male patient, weighting 210.0 lb, was diagnosed with ankylosing spondylitis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: myelitis transverse, neurogenic bladder, . REMICADE dosage: unknown. During the same period patient was treated with PIROXICAM. Patient was hospitalized. Patient recovered.


Rebif Side Effects Report #5521605-0
REBIF problem was reported by a Consumer or non-health professional from BRAZIL on Nov 01, 2007. Male patient, 71 years of age, was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: burn infection, neurogenic bladder, sensory loss, urinary tract infection, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

Taxol Side Effects Report #5427248-1
Health Professional from JAPAN reported TAXOL problem on Aug 23, 2007. Female patient, 55 years of age, was diagnosed with uterine cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: face oedema, neurogenic bladder, . TAXOL dosage: unknown. During the same period patient was treated with CARBOMERCK, DECADRON, RESTAMIN, KYTRIL, MAGLAX. Patient was hospitalized. Patient recovered.

Tysabri Side Effects Report #5692554-2
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2008. Female patient, 52 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: infection, neurogenic bladder, pneumonia, quadriplegia, urinary tract infection, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient died on 03/16/2008.

Avonex Side Effects Report #5320247-X
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Apr 18, 2007. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, neurogenic bladder, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Extra Side Effects Report #5622709-4
EXTRA STRENGTH TYLENOL problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 26, 2008. Female patient, 25 years of age, was diagnosed with insomnia, arthralgia and was treated with EXTRA STRENGTH TYLENOL. After drug was administered, patient experienced the following problems/side effects: bladder disorder, dizziness, neurogenic bladder, pallor, presyncope, . EXTRA STRENGTH TYLENOL dosage: unknown. During the same period patient was treated with EXTRA STRENGTH TYLENOL. Patient recovered.

Spiriva Side Effects Report #5623645-X
Consumer or non-health professional from JAPAN reported SPIRIVA problem on Feb 07, 2008. Male patient, weighting 163.1 lb, was diagnosed with bronchitis chronic, cough, cardiac failure congestive and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, diverticulitis, neurogenic bladder, . SPIRIVA dosage: unknown. During the same period patient was treated with CODEINE PHOSPHATE, LASIX, DILTIAZEM, ASPIRIN, SEPAMIT, ITOROL. Patient was hospitalized. Patient recovered.

Spiriva Side Effects Report #5632451-1
SPIRIVA problem was reported by a Consumer or non-health professional from JAPAN on Feb 18, 2008. Male patient, weighting 163.1 lb, was diagnosed with bronchitis chronic, cough, cardiac failure congestive and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, diverticulitis, neurogenic bladder, . SPIRIVA dosage: unknown. During the same period patient was treated with CODEINE PHOSPHATE, LASIX, DILTIAZEM, ASPIRIN, SEPAMIT, ITOROL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5633208-8
Physician from JAPAN reported VELCADE problem on Feb 05, 2008. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anorexia, interstitial lung disease, neurogenic bladder, neuropathy peripheral, platelet count decreased, pleural effusion, syncope, . VELCADE dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, PURSENNID, MAGNESIUM OXIDE, LANSOPRAZOLE, KYTRIL, POLYETHYLENE GLYCOL, LOPERAMIDE. Patient was hospitalized and became disabled. Patient recovered.

Mylotarg Side Effects Report #5584230-1
MYLOTARG problem was reported by a Physician from JAPAN on Dec 25, 2007. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia, neutropenia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, hyperbilirubinaemia, neurogenic bladder, pneumonia, venoocclusive liver disease, . MYLOTARG dosage: unknown. During the same period patient was treated with PREDONINE, VANCOMYCIN, MEROPENEM, AMBISOME. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5505514-9
Physician from JAPAN reported MYLOTARG problem on Oct 25, 2007. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia, neutropenia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, hyperbilirubinaemia, neurogenic bladder, pneumonia, . MYLOTARG dosage: unknown. During the same period patient was treated with PREDONINE, VANCOMYCIN, MEROPENEM, AMBISOME. Patient was hospitalized. Patient recovered.

Ribavirin Side Effects Report #5494704-X
RIBAVIRIN problem was reported by a Health Professional from UNITED STATES on Oct 12, 2007. Female patient, 59 years of age, weighting 116.2 lb, was diagnosed with hepatitis c and was treated with RIBAVIRIN. After drug was administered, patient experienced the following problems/side effects: confusional state, hypotension, neurogenic bladder, renal failure acute, . RIBAVIRIN dosage: unknown. During the same period patient was treated with FLONASE, ULTRAM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5502107-4
Physician from JAPAN reported VELCADE problem on Oct 18, 2007. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood beta-d-glucan increased, interstitial lung disease, neurogenic bladder, . VELCADE dosage: unknown. Patient recovered.

Natalizumab Side Effects Report #5404953-4
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on July 23, 2007. Female patient, weighting 124.0 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: abscess, deep vein thrombosis, neurogenic bladder, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5410233-3
Consumer or non-health professional from UNITED STATES reported AVONEX problem on July 31, 2007. Female patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: delirium, kidney infection, neurogenic bladder, urinary tract infection, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5421133-7
NATALIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2007. Male patient, 61 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis, muscle spasticity, neurogenic bladder, rash, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5387114-7
Consumer or non-health professional from UNITED STATES reported AVONEX problem on June 26, 2007. Female patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: abdominal hernia, fistula, neurogenic bladder, post procedural complication, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5387114-7
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2007. Female patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: abdominal hernia, fistula, neurogenic bladder, post procedural complication, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Tysabri Side Effects Report #5751456-3
Health Professional from UNITED STATES reported TYSABRI problem on May 14, 2008. Female patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: migraine, multiple sclerosis relapse, neurogenic bladder, urinary tract infection, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.

Effexor Side Effects Report #5343854-7
EFFEXOR problem was reported by a Pharmacist from UNITED STATES on May 25, 2007. Female patient, weighting 255.7 lb, was diagnosed with depression, sleep disorder and was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, dysuria, neurogenic bladder, urinary hesitation, . EFFEXOR dosage: unknown. During the same period patient was treated with SEROQUEL. Patient was hospitalized. Patient recovered.

Zeldox Side Effects Report #5344467-3
Physician from GERMANY reported ZELDOX problem on May 23, 2007. Female patient was diagnosed with schizoaffective disorder and was treated with ZELDOX. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, hyperhidrosis, neurogenic bladder, urinary incontinence, weight increased, . ZELDOX dosage: DAILY DOSE:80MG-FREQ:DAILY. During the same period patient was treated with VALPROATE, NOVONORM, METFORMIN, CARVEDILOL, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Vesicare Side Effects Report #5285282-9
VESICARE problem was reported by a Physician from JAPAN on Mar 13, 2007. Male patient, 68 years of age, was diagnosed with hypertonic bladder and was treated with VESICARE. After drug was administered, patient experienced the following problems/side effects: faecal incontinence, hydronephrosis, neurogenic bladder, postrenal failure, tremor, urinary retention, . VESICARE dosage: 5 MG, UID/QD, ORAL. During the same period patient was treated with OLMETEC, FLUITRAN, TAKEPRON, HARNAL, BAYASPIRINLET. Patient was hospitalized. Patient recovered.